December 24, 2019 : DCMS #481

The Best of 2019, Part 1

In this special year-end issue, we count down our most popular articles from the first half of 2019.

This is the time of year when news slows down and Editors struggle to put newsletters together, so you often get reruns of what the editorial staff liked best. We do things a little different. We figure the best articles are the ones you read the most, not what Steve, Maryanne or I like the best. 

So this week we are sharing our most popular articles according to you, our readers and supporters. Today we have the best article each month for the first half of 2019 and on Saturday, you guessed it, we will have the rest of the year.

Happy Holidays and Best Wishes from the entire staff here at Diabetes in Control.

Dave Joffe

Editor-in-chief

If this happens in my practice, I’m sure it likely happens with your patients too.

So many of our patients take metformin. They may be new to using metformin or have been taking it for many years. Either way it’s not unusual to have untoward GI side effects from taking it. They may have done fine taking it for years, so they don’t even think about it being their metformin.

Optimism correlated with lower incidence of type 2 in postmenopausal women.

Reusable smart insulin pens to launch first, followed by Bluetooth attachment for disposable pens later in 2019.

We asked the DIC advisory board to comment on the use of metformin in patients who do not have diabetes:

Your patients may have asked about it or, if not yet, they most likely will. What is your comment on whether you recommend metformin for people who do not have diabetes? If you do not, how do you respond to patients who ask about it? If you do, what do you tell your patients? And what do you say to your patients when their other health care providers tell them this is a diabetes drug and they should only be taking it if they have diabetes?

Here’s how they responded.

Half of those misdiagnosed were still being treated as though they had type 2 diabetes 13 years later.

An updated consensus report from the American Diabetes Association has pushed focus towards nutrition therapy as a viable alternative to classic pharmacotherapy.